Feature

‘Larger-than-life’ physician Stephen Schwartz dies of COVID-19 at 78


 

Stephen M. Schwartz, MD, PhD, a pioneer in the field of vascular biology and a longtime professor of pathology at the University of Washington, Seattle, died March 17, 2020, after being hospitalized with COVID-19. He was 78.

“This has become all too real,” UW president Ana Mari Cauce said on Facebook, where she described Dr. Schwartz as “larger than life,” and superimposed a photo of him in front of Mount Rainier, according to a report in the Seattle Times.

Dr. Schwartz is “rightfully considered a giant among investigators of the biology of smooth muscle cells and the structure of blood vessels,” Paul Ramsey, MD, CEO of UW Medicine, said in a statement. He will be remembered for his “vigorous advocacy for research and for the field of vascular biology as well as for his many trainees who have gone on to great success as independent investigators in the field of vascular pathobiology,” Dr. Ramsey said.

Dr. Schwartz received a BA in biology from Harvard University in 1963 and an MD from Boston University in 1967. Dr. Schwartz started a residency in the UW department of pathology in 1967 and received his PhD from the institution in 1973. From 1974 to 1979, he was an assistant professor of pathology and became a full professor in 1984.

Dr. Schwartz was also an adjunct professor in the UW departments of bioengineering and medicine, “reflective of his many collaborative relationships with faculty in other departments in our medical school and in the world,” Dr. Ramsey said.

“Dr. Schwartz left a lasting imprint on the UW School of Medicine and the broader scientific community. He will be greatly missed,” he added.

‘A great loss’

Dr. Schwartz chaired numerous national and international meetings in the field of vascular biology. He was the founding chair of the Gordon Research Conference on Vascular Biology and a cofounder and second president of the North American Vascular Biology Organization (NAVBO). He created NAVBO’s flagship summer course, Vasculata.

“The NAVBO community has suffered a great loss,” Bernadette Englert, executive officer for the organization, said in a statement. He will be “sorely missed by generations of vascular biologists and pathologists.”

News of Dr. Schwartz’s passing lit up Twitter. Here are just a few comments:

UW lost to COVID-19 “beloved professor Stephen Schwartz, a pioneer in vascular biology and a larger-than-life scientist. Steve, you will be missed!” Rong Tian, MD, PhD, with the bioengineering department, wrote in a tweet.

“Stephen Schwartz was a giant in vascular biology and a mentor to countless faculty and trainees, including myself. He will be deeply missed,” said Kelly Stevens, PhD, also from the bioengineering department.

A version of this article originally appeared on Medscape.com.

Recommended Reading

How long is it safe to delay gynecologic cancer surgery?
MDedge Psychiatry
CDC coronavirus testing decision likely to haunt nation for months to come
MDedge Psychiatry
High rate of asymptomatic COVID-19 seen in cruise ship passengers
MDedge Psychiatry
Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection
MDedge Psychiatry
Three COVID-19 rapid diagnostic tests get FDA thumbs-up
MDedge Psychiatry
COVID-19 critical care guideline offers support for frontline clinicians
MDedge Psychiatry
FDA issues warning on fecal transplant transmission of SARS-CoV-2
MDedge Psychiatry
Tribes Outperform Federal Government in COVID-19 Response
MDedge Psychiatry
FDA to allow alternative respiratory devices to treat COVID-19
MDedge Psychiatry
Week-old COVID-19 urology guidelines already outdated
MDedge Psychiatry